Lung cancer trials in Greece

In Greece 70 Also abroad 2733

70 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Where
Athens, Cholargos, Larissa, Maroussi, Pireas, Pylea, Thessaloniki
Age
18 years and over
People
714 worldwide
Run by
Pfizer
See details and how to joinNCT06758401 · EU 2024-517968-36-00
Phase 3Taking people
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Where
Athens, Efkarpia, Larissa, Pireas, Thessaloniki
Age
18 years and over
People
830 worldwide
Run by
AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00
Phase 3Taking people
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Where
Athens, Pireas, Thessaloniki
Age
18 years and over
People
531 worldwide
Run by
AbbVie
See details and how to joinNCT07365241 · EU 2025-523819-11-00
Phase 2Taking people
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
Where
Athens
Age
18 years and over
People
48 worldwide
Run by
ETOP IBCSG Partners Foundation
See details and how to joinNCT07203053 · EU 2025-522288-13-00
Phase 3Taking people
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Where
Athens, Cholargos, Patras, Pireas, Thessaloniki
Age
18 years and over
People
780 worldwide
Run by
Summit Therapeutics
See details and how to joinNCT06767514 · EU 2024-518629-14-00
Phase 3Taking people
Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)
Where
Athens, Heraklion, Larissa, Thessaloniki
Age
18 years and over
People
168 worldwide
Run by
Amgen Inc.
See details and how to join2026-525489-23-00 · EU 2026-525489-23-00
Phase 3Taking people
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
Where
Kifissia
Age
18 years and over
People
87 worldwide
Run by
Astrazeneca AB
See details and how to joinNCT05303532 · EU 2023-507337-22-00
Phase 3Taking people
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer
Where
Athens, Larissa, Patras, Pireas, Thessaloniki
Age
18 years and over
People
355 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2024-515884-69-00 · EU 2024-515884-69-00
Phase 3Taking people
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Where
Athens, Chaïdári, Thessaloniki
Age
18 years and over
People
36 worldwide
Run by
Arrivent Biopharma Inc.
See details and how to join2025-522151-26-00 · EU 2025-522151-26-00
Phase 3Taking people
Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
Where
Athens, Thessaloniki
Age
18 years and over
People
156 worldwide
Run by
Amgen Inc.
See details and how to join2024-520050-38-00 · EU 2024-520050-38-00
Phase 3Taking people
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Where
Athens, Larissa, Patras, Pireas, Thessaloniki
Age
18 years and over
People
540 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00
Phase 2Taking people
Study of pre- and post-surgery treatment with IPH5201 and durvalumab in participants with lung cancer (MATISSE)
Where
Chaïdári
Age
18 years to 64 years
People
69 worldwide
Run by
Innate Pharma
See details and how to join2023-507778-42-00 · EU 2023-507778-42-00
Phase 2Taking people
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Where
Athens, Ioannina, Pátrai
Age
18 years and over
People
70 worldwide
Run by
Innate Pharma
See details and how to joinNCT05742607
Phase 2Not yet taking people in Greece
Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
Where
Athens, Maroussi, Pireas
Age
18 years and over
People
158 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT07234877 · EU 2025-522985-60-00
No phaseTaking people
Confocal Laser Endomicroscopy VERification
Where
Athens
Age
18 years and over
People
208 worldwide
Run by
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
See details and how to joinNCT06079970
Early phase 1Enrolling by invitation
Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer
Where
Thessaloniki
People
90
Run by
Biogenea Pharmaceuticals Ltd.
See details and how to joinNCT07285434
No phaseTaking people
First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
Where
Athens
Age
18 years to 90 years
People
100
Run by
National and Kapodistrian University of Athens
See details and how to joinNCT06946498
No phaseTaking people
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Where
Athens
Age
18 years to 85 years
People
111 worldwide
Run by
Oncology Center of Biochemical Education And Research
See details and how to joinNCT06717243
No phaseNot yet taking people in Greece
Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)
Where
Athens
Age
18 years to 75 years
People
515
Run by
Mitera Hospital
See details and how to joinNCT06711939
No phaseTaking people
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
Where
Athens
Age
18 years and over
People
2,200 worldwide
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05537922